The role of A1AT in atherosclerosis, obesity and cardiovascular events is well documented [5,49,55,56,57,58,59,60]; however, distinct A1AT haplotypes or other modifying factors may have aggravating or alleviating effects, which may partly explain the conflicting findings of these studies. This evidence concerns the gene SERPINA1 and obesity disorder.